Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ivy Rx vs TRT Nation

Ivy Rx
Graded #178

Higher grade

vs+3.6999999999999957
TRT Nation
Graded #260

Lower grade

The verdict

Ivy Rx takes it — 66.8/100 to 63.1/100.

Ivy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvy Rx +5
62
57
Dose & formulationIvy Rx +4
64
60
Clinical oversightIvy Rx +5
82
77
Labs & monitoringTRT Nation +9
53
62
FulfillmentIvy Rx +16
81
65
Contract termsEven
55
55
Ivy Rx · left barTRT Nation · right bar

The numbers

MetricIvy RxTRT Nation
WeighScore66.8/10063.1/100
GradeCC
Scorecard rank#178#260
Semaglutide$175/mo (starting dose, compounded)Not disclosed
Tirzepatide$275/mo (starting dose, compounded)$219/mo
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Ivy Rx

Graded #178 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
TRT Nation

Graded #260 · C

Strengths

  • Flat $219/mo tirzepatide regardless of dose escalation
  • Tirzepatide compounded with B12 to reduce nausea
  • Flat plan includes unlimited virtual provider visits
  • Fully online intake-to-delivery process
  • Compounded from licensed US pharmacies

Where it loses points

  • Weight loss is secondary to core TRT business
  • Specific pharmacy partner and 503A status not disclosed
  • Compounded only; not FDA-approved formulations
  • State licensing list not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard